Prognostic Value of CONUT and PNI on Hemoglobin and Clinical Outcomes of Chronic Kidney Disease Patients: A Systematic Review

  • Galaxy Gen Mahananda Putra Anang Military Medicine Study Program, Faculty of Military Medicine, Republic of Indonesia Defense University (RIDU)
  • Arfiyanti Arfiyanti Department of Nutrient, Faculty of Medicine, Indonesian Defense University, Bogor, Indonesia
  • Arif Rachman Departemen of Cell Biology and Biomolecular, Faculty of Medicine, Indonesian Defense University, Bogor, Indonesia

Abstract

Malnutrition and chronic inflammation are prevalent complications in chronic kidney disease (CKD) that contribute to disease progression and high mortality rates. The Controlling Nutritional Status (CONUT) score and Prognostic Nutritional Index (PNI) are objective immunonutritional tools, yet their comparative prognostic value and specific relationship with hemoglobin decline in CKD patients require comprehensive evaluation. This study aims to systematically analyze the prognostic accuracy of CONUT and PNI scores in predicting clinical outcomes and their correlation with hemoglobin levels in CKD patients. A systematic literature review was conducted via PubMed and Google Scholar for primary cohort studies published between 2023 and 2026. Six studies meeting the inclusion criteria were analyzed qualitatively. The findings demonstrated that high CONUT and low PNI scores were significantly associated with lower hemoglobin levels and a higher risk of malnutrition in CKD patients. Both indices independently predicted adverse clinical outcomes, including renal progression and mortality. PNI consistently showed robust predictive capacity for mortality, while composite scores effectively stratified risk in dialysis populations. In conclusion, the CONUT score and PNI are reliable and cost-effective predictors of adverse clinical outcomes and hemoglobin decline in CKD patients. Routine immunonutritional screening using these indices is essential to optimize clinical management

References

Dubey, V., Reza, N., & Hope, W. (2025). Drug-resistant Acinetobacter baumannii: Mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen. Clinical Microbiology Reviews, 38(3). https://doi.org/10.1128/cmr.00279-24

Gayathri, S. P. K., Dinesh, C., & Lakshmi. (2026). Ceftazidime-avibactam plus aztreonam for carbapenem-resistant Acinetobacter baumannii in respiratory tract infection: A comprehensive review. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18904506

Karakonstantis, S., Ιωάννου, Π., Samonis, G., & Kofteridis, D. P. (2021). Systematic review of antimicrobial combination options for pandrug-resistant Acinetobacter baumannii. Antibiotics, 10(11), 1344. https://doi.org/10.3390/antibiotics10111344

Kumar, V., Yasmeen, N., Pandey, A., Chaudhary, A. A., Alawam, A. S., Rudayni, H. A., Islam, A., Lakhawat, S. S., Sharma, P. K., & Shahid, M. (2023). Antibiotic adjuvants: Synergistic tool to combat multidrug-resistant pathogens. Frontiers in Cellular and Infection Microbiology, 13, 1293633. https://doi.org/10.3389/fcimb.2023.1293633

Saleh, N., Ezzat, H., El-Sayyad, G. S., & Zedan, H. (2024). Regulation of overexpressed efflux pump encoding genes by cinnamon oil and trimethoprim to abolish carbapenem-resistant Acinetobacter baumannii clinical strains. BMC Microbiology, 24(1), 52. https://doi.org/10.1186/s12866-024-03194-8

Singkham-in, U., Higgins, P. G., Wannigama, D. L., Hongsing, P., & Chatsuwan, T. (2020). Rescued chlorhexidine activity by resveratrol against carbapenem-resistant Acinetobacter baumannii via down-regulation of AdeB efflux pump. PLoS ONE, 15(12). https://doi.org/10.1371/journal.pone.0243082

Zack, K. M., Sorenson, T., & Joshi, S. G. (2024). Types and mechanisms of efflux pump systems and the potential of efflux pump inhibitors in the restoration of antimicrobial susceptibility, with a special reference to Acinetobacter baumannii. Pathogens, 13(3), 197. https://doi.org/10.3390/pathogens13030197

Zhai, X., Wu, G., Tao, X., Yang, S., Lv, L., Zhu, Y., Dong, D., & Xiang, H. (2023). Success stories of natural product-derived compounds from plants as multidrug resistance modulators in microorganisms. RSC Advances, 13(12), 7798–7817. https://doi.org/10.1039/d3ra00184a

2026-09-05